Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.
Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.
FASEB J. 2021 May;35(5):e21594. doi: 10.1096/fj.202002645R.
Protein misfolding is a central feature of most neurodegenerative diseases. Molecular chaperones can modulate the toxicity associated with protein misfolding, but it remains elusive which molecular chaperones and co-chaperones interact with specific misfolded proteins. TDP-43 misfolding and inclusion formation are a hallmark of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Using yeast and mammalian neuronal cells we find that Hsp90 and its co-chaperone Sti1 have the capacity to alter TDP-43 misfolding, inclusion formation, aggregation, and cellular toxicity. Our data also demonstrate that impaired Hsp90 function sensitizes cells to TDP-43 toxicity and that Sti1 specifically interacts with and strongly modulates TDP-43 toxicity in a dose-dependent manner. Our study thus uncovers a previously unrecognized tie between Hsp90, Sti1, TDP-43 misfolding, and cellular toxicity.
蛋白质错误折叠是大多数神经退行性疾病的一个核心特征。分子伴侣可以调节与蛋白质错误折叠相关的毒性,但与特定错误折叠的蛋白质相互作用的分子伴侣和共伴侣仍不清楚。TDP-43 错误折叠和包含体形成是肌萎缩侧索硬化症 (ALS) 和其他神经退行性疾病的标志。使用酵母和哺乳动物神经元细胞,我们发现 Hsp90 及其共伴侣 Sti1 具有改变 TDP-43 错误折叠、包含体形成、聚集和细胞毒性的能力。我们的数据还表明,Hsp90 功能受损会使细胞对 TDP-43 毒性敏感,并且 Sti1 特异性地与 TDP-43 相互作用,并以剂量依赖的方式强烈调节 TDP-43 毒性。因此,我们的研究揭示了 Hsp90、Sti1、TDP-43 错误折叠和细胞毒性之间以前未被认识的联系。